Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Real-World Survival and Safety of Isatuximab-Based vs Daratumumab-Based VRd Exposure in Multiple Myeloma

MM - 1202

Real-World Survival and Safety of Isatuximab-Based vs Daratumumab-Based VRd Exposure in Multiple Myeloma

Xiaoyi Zhang

Poster Presenter: Xiaoyi Zhang

Thumbnail for Real-World Incidence of Severe Ventricular Arrhythmias in Patients with Acute Myeloid Leukemia Treated with Quizartinib: Interim Results From a Postmarketing Study

AML - 1204

Real-World Incidence of Severe Ventricular Arrhythmias in Patients with Acute Myeloid Leukemia Treated with Quizartinib: Interim Results From a Postmarketing Study

Akash Nahar

Poster Presenter: Akash Nahar

Previous 1...96 97 98 99 100 101 102...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma: From Surrogate Endpoint Validation to the Unanswered Question of Maintenance-Free Remission

MM - 1205

Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma: From Surrogate Endpoint Validation to the Unanswered Question of Maintenance-Free Remission

Sukhmani Sidhu

Poster Presenter: Sukhmani Sidhu

Thumbnail for Discovery and Characterization of DMR-001, an Fc-Null, Half-Life-Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

MPN - 1206

Discovery and Characterization of DMR-001, an Fc-Null, Half-Life-Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

Mark Benton

Poster Presenter: Mark Benton

Thumbnail for Efficacy and Safety of Venetoclax Plus Azacitidine in Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

AML - 1207

Efficacy and Safety of Venetoclax Plus Azacitidine in Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Fatima Nadeem

Poster Presenter: Fatima Nadeem

Thumbnail for Sex-Based Differences in Hematologic Malignancy Mortality Across Therapeutic Eras in the United States: A CDC WONDER Analysis (1999-2020)

AML - 1208

Sex-Based Differences in Hematologic Malignancy Mortality Across Therapeutic Eras in the United States: A CDC WONDER Analysis (1999-2020)

Nihar Prafullchandra Vavaliya

Poster Presenter: Nihar Prafullchandra Vavaliya

Thumbnail for Whole Genome Sequencing of Patients with Myelodysplastic Syndrome Uncovers Novel, Clinically Relevant Biomarkers Missed by Standard Of Care Methods

MDS - 1210

Whole Genome Sequencing of Patients with Myelodysplastic Syndrome Uncovers Novel, Clinically Relevant Biomarkers Missed by Standard Of Care Methods

Alex Bataller

Poster Presenter: Alex Bataller

Thumbnail for Competing Risks Analysis of Age-Related and Temporal Trends in Acute Myeloid Leukemia Mortality: A SEER-Based Study (2000-2023)

AML - 1211

Competing Risks Analysis of Age-Related and Temporal Trends in Acute Myeloid Leukemia Mortality: A SEER-Based Study (2000-2023)

Ashesh Kumar

Poster Presenter: Ashesh Kumar

Thumbnail for Post-Induction Consolidation With Blinatumomab vs Chemotherapy in First-Relapse B-Cell Acute Lymphoblastic Leukemia: Evidence From Randomized Controlled Trials

ALL - 1212

Post-Induction Consolidation With Blinatumomab vs Chemotherapy in First-Relapse B-Cell Acute Lymphoblastic Leukemia: Evidence From Randomized Controlled Trials

Bashar M Al Zoubi

Poster Presenter: Bashar M Al Zoubi

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors